Pharmaceutical Cold Chain Compliance 2012
April 30 - May 2, 2012
Philadelphia PA , USA
Complying with GDP is key to protecting product integrity and ensuring patient safety.
And you know the consequences of not complying can be disastrous; product recall, a threat to patient wellbeing, reputation damage and a hefty financial loss.
So are you fully prepared for the imminent regulatory changes and can you ensure you still comply from depo right through to the “last mile”. We’ve been researching with the cold chain leaders, including key people at Merck, Sanofi & Lundbeck to design a meeting that specifically addresses the issues that you’ve said are most important right now.
How other companies are preparing for these changes, when will come into play and how will they affect the whole of the supply chain, both home and abroad.
Attend Pharmaceutical Cold Chain Compliance and you will:
• Discover what strategies leading pharma have in place to ensure continued GDP compliance
• Understand the pending regulatory changes and how USP 1079 and GDP can improve product security and reduce the risk of recall
• Hear from other drug developers on their chosen procedures and learn about the most cutting edge technologies to ensure your cold chain is safe, reliable and effective
• Discuss opinions and solutions with the industry for tackling common “last mile” problems and take a host of new ideas back to your company
• Improve your global management strategies and explore the changes in regulations across countries in your supply chain
• Explore the latest advances in active systems and hear how they can guarantee the integrity of your drug during transportation
For more information on what will be covered, or to register your place, please visit www.coldchain-compliance.com or email [email protected].
And you know the consequences of not complying can be disastrous; product recall, a threat to patient wellbeing, reputation damage and a hefty financial loss.
So are you fully prepared for the imminent regulatory changes and can you ensure you still comply from depo right through to the “last mile”. We’ve been researching with the cold chain leaders, including key people at Merck, Sanofi & Lundbeck to design a meeting that specifically addresses the issues that you’ve said are most important right now.
How other companies are preparing for these changes, when will come into play and how will they affect the whole of the supply chain, both home and abroad.
Attend Pharmaceutical Cold Chain Compliance and you will:
• Discover what strategies leading pharma have in place to ensure continued GDP compliance
• Understand the pending regulatory changes and how USP 1079 and GDP can improve product security and reduce the risk of recall
• Hear from other drug developers on their chosen procedures and learn about the most cutting edge technologies to ensure your cold chain is safe, reliable and effective
• Discuss opinions and solutions with the industry for tackling common “last mile” problems and take a host of new ideas back to your company
• Improve your global management strategies and explore the changes in regulations across countries in your supply chain
• Explore the latest advances in active systems and hear how they can guarantee the integrity of your drug during transportation
For more information on what will be covered, or to register your place, please visit www.coldchain-compliance.com or email [email protected].
Related events
Pharmaceutical Cold Chain Compliance April 30 - May 2, 2012
